Alain Schreiber

Alain Schreiber has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Optimer Pharmaceuticals Inc and Eagle Pharmaceuticals, Inc. We count 24 filings; the first trade dates from 14 February 2007 and the latest from 18 February 2014.

Purchases make up the whole of the open-market record (7 purchases, €8.7M). No amount is published for 4 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants. Since January 2014: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €3.4M.

The newest entry dates from 20 February 2014: a transaction, in Eagle Pharmaceuticals, Inc. The clock since the last published purchase (20 February 2014) now reads 4,645 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.